Evidence map›Paper›PMID 19959692›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Utility and relationships of biomarkers of smoking in African-American light smokers.

Man Ki Ho, Babalola Faseru, Won S Choi, Nicole L Nollen, Matthew S Mayo, Janet L Thomas, Kolawole S Okuyemi, Jasjit S Ahluwalia, Neal L Benowitz, Rachel F Tyndale

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Trial
  2. Trial
  3. Trial
  4. A pilot clinical trial of varenicline for smoking cessation in black smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Relationships Between Smoking Behaviors and Cotinine Levels Among Two American Indian Populations With Distinct Smoking Patterns.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Article
  10. Variation in CYP2A6 Activity and Personalized Medicine.Journal of personalized medicine · 2017
    Review
  11. Biomarkers of exposure to new and emerging tobacco delivery products.American journal of physiology. Lung cellular and molecular physiology · 2017
    Review
  12. Article
  13. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Man Ki HoCentre for Addiction and Mental Health and Department of Pharmacology and Toxicology, University of Toronto, Ontario, Canada.
Babalola Faseru
Won S Choi
Nicole L Nollen
Matthew S Mayo
Janet L Thomas
Kolawole S Okuyemi
Jasjit S Ahluwalia
Neal L Benowitz
Rachel F Tyndale
University of Minnesota · USUniversity of Kansas Medical Center · USUniversity of Minnesota Medical Center · USUniversity of Toronto · CACentre for Addiction and Mental Health · CA

Funding

Research Support CoreP30DA012393 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ST.HELEN, GIDEON · 1999 to 2024
$17.1M
PHARMACOKINETICS &PHARMACODYNAMICS OF NICOTINER01DA002277 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BENOWITZ, NEAL L · 1985 to 2012
$6.3M
Helping African American Light Smokers QuitR01CA091912 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI COX, LISA SANDERSON · 2001 to 2010
$5.6M
Kansas BIRCWH Career Development Program Women's HealthK12HD052027 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CARLSON, SUSAN E · 2005 to 2014
$5.0M
PHARMACOKINETICS AND PHARMACODYNAMICS OF NICOTINER37DA002277 · NIDA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BENOWITZ, NEAL L · 1993 to 2002
$1.6M
Addressing Light Smoking in African AmericansK07CA090334 · NCI · UNIVERSITY OF MINNESOTA · PI OKUYEMI, KOLAWOLE S · 2001 to 2006
$655k
CIHR 86471CIHR MOP86471NCI NIH HHS CA91912NCI NIH HHS K07 CA090334NCI NIH HHS R01 CA091912NICHD NIH HHS K12 HD052027NIDA NIH HHS DA02277NIDA NIH HHS DA12393NIDA NIH HHS P30 DA012393NIDA NIH HHS R01 DA002277NIDA NIH HHS R37 DA002277
6 · The paper itself

Abstract

Although expired carbon monoxide (CO) and plasma cotinine (COT) have been validated as biomarkers of self-reported cigarettes per day (CPD) in heavy smoking Caucasians, their utility in light smokers is unknown. Further, variability in CYP2A6, the enzyme that mediates formation of COT from nicotine and its metabolism to trans-3'-hydroxycotinine (3HC), may limit the usefulness of COT. We assessed whether CO and COT are correlated with CPD in African-American light smokers (< or =10 CPD, n = 700), a population with known reduced CYP2A6 activity and slow COT metabolism. We also examined whether gender, age, body mass index, smoking mentholated cigarettes, or rate of CYP2A6 activity, by genotype and phenotype measures (3HC/COT), influence these relationships. At baseline, many participants (42%) exhaled CO of < or =10 ppm, the traditional cutoff for smoking, whereas few (3.1%) had COT below the cutoff of < or =14 ng/mL; thus, COT seems to be a better biomarker of smoking status in this population. CPD was weakly correlated with CO and COT (r = 0.32-0.39, P < 0.001), and those reporting fewer CPD had higher CO/cigarette and COT/cigarette, although the correlations coefficients between these variables were also weak (r = -0.33 and -0.08, P < 0.05). The correlation between CPD and CO was not greatly increased when analyzed by CYP2A6 activity, smoking mentholated cigarettes, or age, although it appeared stronger in females (r = 0.38 versus 0.21, P < 0.05) and obese individuals (r = 0.38 versus 0.24, P < 0.05). Together, these results suggest that CO and COT are weakly associated with self-reported cigarette consumption in African-American light smokers, and that these relationships are not substantially improved when variables previously reported to influence these biomarkers are considered.

Indexed as

Black or African AmericanAdultAgedAged, 80 and overAryl Hydrocarbon HydroxylasesBiomarkers, PharmacologicalCarbon MonoxideCotinineCytochrome P-450 CYP2A6Double-Blind MethodFemaleGenotypeHumansMaleMiddle AgedPlacebosAryl Hydrocarbon HydroxylasesBiomarkers, PharmacologicalCarbon MonoxideCotinineCYP2A6 protein, humanCytochrome P-450 CYP2A6Placebos

Identifiers

PMID19959692
PMCPMC2791893
OpenAlexW2146308509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.